company background image
NGM logo

NGM Biopharmaceuticals NasdaqGS:NGM Stok Raporu

Son Fiyat

US$1.54

Piyasa Değeri

US$128.5m

7D

-3.1%

1Y

-59.8%

Güncellenmiş

05 Apr, 2024

Veri

Şirket Finansalları +

NGM Biopharmaceuticals, Inc.

NasdaqGS:NGM Stok Raporu

Piyasa değeri: US$128.5m

NGM Stoklara Genel Bakış

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer.

NGM Biopharmaceuticals, Inc. Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti NGM Biopharmaceuticals
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$1.54
52 Haftanın En Yüksek SeviyesiUS$4.69
52 Haftanın En Düşük SeviyesiUS$0.60
Beta1.27
11 Aylık Değişim1.32%
3 Aylık Değişim14.93%
1 Yıllık Değişim-59.79%
33 Yıllık Değişim-93.94%
5 Yıllık Değişim-90.41%
Halka arzdan bu yana değişim-89.52%

Son Haberler & Güncellemeler

Recent updates

What NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) 32% Share Price Gain Is Not Telling You

Dec 19
What NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) 32% Share Price Gain Is Not Telling You

We're A Little Worried About NGM Biopharmaceuticals' (NASDAQ:NGM) Cash Burn Rate

Oct 05
We're A Little Worried About NGM Biopharmaceuticals' (NASDAQ:NGM) Cash Burn Rate

Some Analysts Just Cut Their NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Estimates

Aug 09
Some Analysts Just Cut Their NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Estimates

Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Could Be Quite Risky

Jun 27
Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Could Be Quite Risky

NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) Business Is Trailing The Industry But Its Shares Aren't

Apr 17
NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) Business Is Trailing The Industry But Its Shares Aren't

We Think NGM Biopharmaceuticals (NASDAQ:NGM) Needs To Drive Business Growth Carefully

Dec 20
We Think NGM Biopharmaceuticals (NASDAQ:NGM) Needs To Drive Business Growth Carefully

NGM Biopharma sinks ~72% after phase 2 trial of its eye degeneration treatment fails

Oct 17

NGM Biopharmaceuticals appoints CFO Siobhan Nolan Mangini to the additional role of President

Jun 30

NGM Biopharmaceuticals: Eye Disorder Data Due Second Half Of 2022

Jun 21

Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth

Jun 15
Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth

Analysts Are Betting On NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) With A Big Upgrade This Week

May 09
Analysts Are Betting On NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) With A Big Upgrade This Week

NGM Biopharmaceuticals: How They Changed A Dead End To A Crossroad

Apr 26

Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth

Feb 21
Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth

We're Hopeful That NGM Biopharmaceuticals (NASDAQ:NGM) Will Use Its Cash Wisely

Nov 08
We're Hopeful That NGM Biopharmaceuticals (NASDAQ:NGM) Will Use Its Cash Wisely

Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth

Jul 09
Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Mar 06
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Hissedar Getirileri

NGMUS PharmaceuticalsUS Pazar
7D-3.1%-3.4%-1.2%
1Y-59.8%17.1%30.6%

Getiri vs. Endüstri: NGM geçen yıl % 17.1 oranında getiri sağlayan US Pharmaceuticals sektörünün gerisinde kaldı.

Getiri vs Piyasa: NGM geçen yıl % 30.6 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is NGM's price volatile compared to industry and market?
NGM volatility
NGM Average Weekly Movement10.3%
Pharmaceuticals Industry Average Movement9.3%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

İstikrarlı Hisse Senedi Fiyatı: NGM hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: NGM 'nin haftalık oynaklığı ( 10% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
2007138David Woodhousewww.ngmbio.com

NGM Biopharmaceuticals, Inc. Temel Bilgiler Özeti

NGM Biopharmaceuticals'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
NGM temel i̇stati̇sti̇kler
Piyasa değeriUS$128.53m
Kazançlar(TTM)-US$142.37m
Gelir(TTM)US$4.42m

29.1x

P/S Oranı

-0.9x

F/K Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
NGM gelir tablosu (TTM)
GelirUS$4.42m
Gelir MaliyetiUS$114.23m
Brüt Kâr-US$109.81m
Diğer GiderlerUS$32.56m
Kazançlar-US$142.37m

Son Raporlanan Kazançlar

Dec 31, 2023

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)-1.71
Brüt Marj-2,486.12%
Net Kâr Marjı-3,223.34%
Borç/Özkaynak Oranı0%

NGM uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün